Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

MET

MET Declares Q4 2025 Preferred Stock Dividends

Metlife, Inc. (NYSE: MET) has declared its fourth quarter 2025 preferred stock dividends. The company announced several dividends, including a quarterly dividend of $0.33489390 per share on its floating rate non-cumulative preferred stock, series A, with a liquidation preference of $25 per share (NYSE: MET PRA). Additionally, a quarterly dividend of $351.5625 per share was declared on the company’s 5.625% non-cumulative preferred stock, series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE: MET PRE). Furthermore, a quarterly dividend of $296.875 per share was declared on the company’s 4.75% non-cumulative preferred stock, series F, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.296875 per depositary share (NYSE: MET PRF).

The above dividends will be payable on December 15, 2025, to shareholders of record as of Friday, November 28, 2025. This is due to the record date occurring on Sunday, November 30, 2025. Metlife, Inc. is a leading financial services company that provides insurance, annuities, employee benefits, and asset management to individual and institutional customers globally.

The market has reacted to these announcements by moving the company's shares -3.92% to a price of $75.56. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS